Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis

Motohisa Yamamoto, Hiroki Takahashi, Hideki Wakasugi, Yasutaka Sukawa, Mayuko Saito, Chisako Suzuki, Yasuyoshi Naishiro, Hiroyuki Yamamoto, Yasuhisa Shinomura, Kohzoh Imai

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)


A 74-year-old Japanese woman was diagnosed with rheumatoid arthritis due to polyarthralgia. She was prescribed various disease-modifying anti-rheumatic drugs, but most of them were discontinued because of side effects or poor effectiveness. She was referred to our hospital in 2004, and etanercept was administered from June 2005. This resulted in rapid improvement of polyarthritis; however, she developed disorientation from February 2006. She was admitted to our hospital because of convulsions and loss of consciousness. She was diagnosed with progressive multifocal leukoencephalopathy on the basis of clinical symptoms and magnetic resonance imaging of the brain. In this significant and important case, leukoencephalopathy occurred during etanercept administration, and we refer to the risk of anti-TNFα drugs.

Original languageEnglish
Pages (from-to)72-74
Number of pages3
JournalModern rheumatology
Issue number1
Publication statusPublished - 2007 Feb
Externally publishedYes


  • Elderly
  • Etanercept
  • Leukoencephalopathy
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this